---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-044891"
form_type: "8-K"
ticker: "BCTX"
cik: "0001610820"
company_name: "BriaCell Therapeutics Corp."
filed_at: "2023-12-14T23:59:59+00:00"
generated_at: "2026-06-07T12:50:48.291291+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# BriaCell's BriaPro subsidiary posts Q1 loss of $128K; holds $211K in intangible assets

## Summary
- BriaPro completed spin-out from BriaCell on Aug 31, 2023, receiving Bria-TILsRx and PKCδ inhibitor assets.
- Net loss of $128K for three months ended Oct 31, 2023; no revenue; operating loss $132K.
- Intangible assets (patents) of $211K net; cash and equivalents of $1; accumulated deficit $148K.
- Going concern uncertainty noted; BriaPro needs additional financing to continue operations.
- BriaCell owns 2/3 of BriaPro; provides transition services for $20K/month.

## SEC filing metadata
- accession: 0001493152-23-044891
- form_type: 8-K
- ticker: BCTX
- cik: 0001610820
- company_name: BriaCell Therapeutics Corp.
- filed_at: 2023-12-14T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610820/000149315223044891/0001493152-23-044891-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610820/000149315223044891/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-044891
- JSON: https://secwatch.observer/filing/0001493152-23-044891.json
- Plain text: https://secwatch.observer/filing/0001493152-23-044891.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.